Abstract
Growth hormone (GH) therapy in children with small for gestational age (SGA) has been shown to be of significant therapeutic benefit. We report the case of an 11-year-old Caucasian male who developed early adrenarche, hypertension and insulin resistance on GH therapy for SGA and profound short stature (ht −5 SD). This patient demonstrated a poor response to GH therapy and developed physical and biochemical findings of insulin resistance responsive to metformin therapy. He remained hypertensive, however, and continued to have elevated serum dehydroepiandrosterone sulfate levels. Urinary free cortisol excretion was subsequently found to be elevated. The diagnosis of Cushing’s disease was confirmed with inferior petrosal sinus sampling and pituitary MRI. The patient underwent partial adenohypophysectomy with resulting normalization of plasma cortisol levels and associated symptoms. Our patient’s diagnosis of Cushing’s disease was complicated by his past history of poor growth since birth and history of SGA. The signs of Cushing’s disease did not overtly appear until GH therapy was initiated to help treat severe short stature. It is possible that the metabolic effects of GH therapy unmasked the presence of underlying Cushing’s disease.
References
Karlberg J, Albertson-Wikland K (1995) Growth in full term small for gestational age infants from birth to final height. Pediatr Res 38:733–739
Saenger P, Czernichow P, Hughes I, Reiter E (2007) Small for gestational age: short stature and beyond. Endocr Rev 28(2):219–251
Delemarre EM, Rotteveel J, Delemarre-van de Waal HA (2007) Metabolic implications of GH treatment in small for gestational age. Eur J Endocrinol 157:S47–S50
Dunger D, Ong K (2005) Babies born small for gestational age: insulin sensitivity and growth hormone treatment. Horm Res 64(Suppl 3):58–65
Cutfield WS, Wilton P, Benmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth hormone treatment. Lancet 355:610–613
Magiakou M, Mastorakos G, Gomez T, Rose S, Chrousos G (1994) Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J Clin Endocrinol Metab 78:131–137
Savage M, Storr H, Chan L, Grossman A (2007) Diagnosis and treatment of pediatric Cushing’s disease. Pituitary 10:365–371
Kotake M, Nakai A, Mokuno T, Oda N, Sawai Y, Itoh Y, Shimazaki K, Kato R, Hayakawa N, Uchikawa A, Oiso A, Hirooka Y, Mitsuma Y, Itoh T, Nagasaka A (1996) Short stature due to growth hormone deficiency associated with Cushing’s disease and ulcerative colitis. Horm Metab Res 28(10):565–569
Acknowledgments
Thank you to Edward Oldfield MD; Crutchfield Professor of Neurosurgery & Professor of Internal Medicine, Department of Neurological Surgery, University of Virginia for his assistance in providing education and details of the surgical aspects of this case.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heneghan, M., Alemzadeh, R. Cushing disease as possible cause of persistent growth failure despite growth hormone therapy in a small for gestational age male. Pituitary 14, 409–413 (2011). https://doi.org/10.1007/s11102-009-0201-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-009-0201-3